Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug;46(8):4051-4055.
doi: 10.1007/s10072-025-08186-8. Epub 2025 Apr 25.

Stroke, idiopathic thrombocytopenic purpura and avatrombopag: two cases of coincident events

Bernat Boy  1 , Gloria Iacoboni  2 , David Valcárcel  2 , Carlos Molina  3   4 , Marc Rodrigo-Gisbert  5   6
Affiliations

Stroke, idiopathic thrombocytopenic purpura and avatrombopag: two cases of coincident events

Bernat Boy et al. Neurol Sci. 2025 Aug.
No abstract available

Keywords: Avatrombopag; Idiopathic thrombocytopenic purpura; Stroke.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethical approval: This research adhered to the tenets of the Declaration of Helsinki. Competing interests: Authors report no conflicts of interest. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Markham A (2021) Avatrombopag: A review in thrombocytopenia. Drugs 81:1905–1913. https://doi.org/10.1007/s40265-021-01613-y - DOI - PubMed - PMC
    1. Bussel JB et al (Jun. 2014) A randomized trial of Avatrombopag, an investigational thrombopoietin- receptor agonist, in persistent and chronic immune thrombocytopenia. Blood 123:3887–3894. https://doi.org/10.1182/blood-2013-07-514398
    1. Jurczak W et al (Nov. 2018) Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia Br J Haematol 183(3):479–490. https://doi.org/10.1111/bjh.15573
    1. Kuter DJ (May. 1 2022) The structure, function, and clinical use of the thrombopoietin receptor agonist avatrombopag. Churchill Livingstone https://doi.org/10.1016/j.blre.2021.100909
    1. Rodeghiero F (Jan. 2016) Is ITP a thrombophilic disorder? Am J Hematol 91(1):39–45. https://doi.org/10.1002/ajh.24234

LinkOut - more resources